High-Risk Factors and Therapeutic Advances in Ovarian Cancer

• Published in: Zhongliu fangzhi yanjiu Vol. 52; no. 7; pp. 637 - 644
• Main Authors: Sha, Xiaoyu, Zuo, Weiwei, Gan, Jing, Liu, Yankun
• Format: Journal Article
• Language: Chinese; English
• Published: Tianjin China Anti-Cancer Association 2025; Magazine House of Cancer Research on Prevention and Treatment
• Subjects: brca1/2; Cancer; genetic testing; Malignancy; Ovarian cancer; parp inhibitors; Ribose; Risk factors; treatment
• ISSN: 1000-8578
• DOI: 10.3971/j.issn.1000-8578.2025.24.1243

Among gynecologic malignancies, ovarian cancer is the most lethal, primarily due to its insidious early symptoms, lack of effective screening methods, and high risk of recurrence. It poses substantial challenges to clinical diagnosis and treatment. In recent years, the clinical application of poly A...